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Enteroendocrine cells (EECs) control a wide range of physiological processes linked to 29 
metabolism1. We show that EECs hormones are differentially expressed between crypts 30 
(e.g. Glp1) and villi (e.g. Secretin). As demonstrated by single cell mRNA sequencing, 31 
BMP4 signals can reprogram the expressed repertoire of hormones of individual EECs in 32 
murine Lgr5+ intestinal stem cell-derived organoids. Accordingly, BMP4 induces hormone 33 
switching of EECs migrating up the crypt-villus axis in vivo. This implies the existence of 34 
fewer EEC lineages in the small intestine than proposed previously. We also describe a 35 
protocol to generate human EECs in organoids and demonstrate that BMP signaling 36 
regulates hormone expression in a similar fashion. These observations suggest strategies to 37 
pharmacologically manipulate numbers of EECs expressing therapeutically relevant 38 
hormones, such as Glp1.  39 
The EECs of the intestine together constitute the largest hormone-producing organ in mammals. 40 
EECs are classified according to their hormone products1. Enterochromaffin cells (ECs) produce 41 
Serotonin, a regulator of intestinal motility, and Tachykinin 1 (Tac1), also known as Substance 42 
P, a peptide which is believed to play a role in muscle contraction and inflammation2. L-cells 43 
produce Glp1, an inducer of insulin release encoded by the Glucagon (Gcg) gene, and can co-44 
express Pyy1. Other EEC subtypes include Gastric inhibitory protein (Gip)-producing K-cells, 45 
Somatostatin (Sst)-producing D-cells, Cholestocystokinin (Cck)-producing I-cells, Neurotensin 46 
(Nts)-producing N-cells and Secretin (Sct)-producing S-cells1. Although this classification 47 
suggests well-defined, distinct subtypes of EECs, these hormones are often co-expressed 48 
suggesting considerable overlap between lineages3,4. Like all other cell types of the intestinal 49 
epithelium, the short-lived EECs are constitutively produced by Lgr5+ crypt stem cells5. Lgr5 50 
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stem cells can be cultured to generate epithelial organoids that faithfully recapitulate gut 51 
epithelial biology6. Single cell sequencing has shown that a complete set of EECs subtypes is 52 
produced in these mini-guts, including some that had previously gone unnoticed in intact gut7,8. 53 
However, extrinsic factors that control EEC subtype identity have remained largely unknown. 54 
Previous work has suggested that EECs expressing Tac1 and Glp1 are restricted to crypts, while 55 
Sct-, Pyy- and Nts-producing EECs are enriched in villi9,10. In agreement with these studies, we 56 
found that ileal L-cells co-express Glp1 and Pyy in the crypt, but mostly lack Glp1 in the villus 57 
(Fig. 1a-c, Fig. S1a). Serotonin-producing ECs occur along the length of the crypt-villus axis, but 58 
selectively co-express Tac1 in the crypt and Sct in the villus (Fig. 1d-e, Fig. S1a). To address if 59 
hormone switching occurs during migration of EECs along the crypt-villus axis, we analyzed 60 
intestines from Tac1iresCre /RosatdTomato mice, an allele which faithfully labels all Tac1+/Serotonin+ 61 
cells in the crypt (Fig. 1f)11. In adult intestines, almost all Serotonin+ cells were marked by 62 
tdTomato (Fig.1g). Importantly, >55% of Sct+ cells on villi were also traced, while being 63 
negative for Tac1 (Fig. 1f-g, S1b). The rarity of tdTomato+ cells that were negative for Serotonin 64 
suggests that ECs do not lose Serotonin during their lifetime to become single Sct+ as previously 65 
suggested9,12. Sct+ cells that are not traced by Tac1 and are Serotonin-negative must thus be part 66 
of another EEC lineage. EECs producing other hormones, including Cck, Gip and Sst, were only 67 
very rarely derived from Tac1+ progenitors (Fig. 1g, S1b). These tracing data implied lineage 68 
relationships between crypt and villus EECs, i.e that Tac1-/Sct+ ECs on villi derive from Tac1+ 69 
crypt ECs. This in turn suggested that local niche signals could induce shifts in hormone 70 
expression.  71 
 72 
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Multiple signaling gradients exist along the crypt-villus axis, e.g. Wnt levels are high at the crypt 73 
base, while BMP is highest at the villus tips13,14. Induction of EECs in murine intestinal 74 
organoids can be achieved through inhibition of the Wnt, MAPK and Notch signaling pathways, 75 
in the presence of the BMP inhibitor Noggin8. We used this differentiation system as a starting 76 
point to modulate selected signaling pathways8, while monitoring Sct and Gcg as a proxy of the 77 
villus- and crypt-hormone signatures respectively. Strikingly, we observed that all ECs in this 78 
culture co-expressed Serotonin and Tac1, while Sct was absent (Fig. 2a). This suggests niche 79 
signals acting on EECs are dominant over a default, temporal differentiation process. 80 
Manipulation of the Wnt, TGFβ and Hedgehog pathways did either reduce both Gcg and Sct 81 
transcripts, or had no significant on any assessed hormone (Fig. S2a).  We then replaced Noggin 82 
by BMP4 in this EEC differentiation cocktail ('EEC BMPhigh' medium), generating cells 83 
immunoreactive for Sct, as well as ECs lacking Tac1 (Fig. 2a-b). Glp1+ cell numbers and total 84 
levels of secreted Glp1 were greatly diminished (Fig. 2a-c, S2b). We next performed bulk RNA 85 
sequencing on duodenal and ileal organoids stimulated with EEC BMPhigh or EEC BMPlow media 86 
(Fig. 2d), and validated the expression of selected genes by qPCR (Fig. 2e). EEC markers which 87 
are homogenously distributed on crypts and villi (Chga, Tph1 (enzyme catalyzing Serotonin 88 
production), Cck and duodenal Gip) are only mildly affected by BMP activation (Fig. 2d-e). We 89 
did observe an increase in Sct and a minor upregulation of Pyy and Nts (Fig. 2d-e), which are 90 
expressed highest in the villus10. Sct is reported to be enriched in the proximal part of the SI1, but 91 
we observe that our EEC differentiation protocol generates Sct+ cells equally well in the proximal 92 
and distal SI organoids. Trpa1, an irritant receptor enriched in EECs of the intestinal crypt15, 93 
decreased with BMP activation (Fig. 2d). BMP4-mediated changes in hormone expression could 94 
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be overridden by the addition of BMPR1a inhibitor LDN193189, confirming involvement of the 95 
BMPR1/2 axis (Fig. S2c-d).  96 
To address whether BMP signaling can switch hormone expression in individual mature EECs 97 
rather than selectively depleting subtypes of EECs, we followed the fate of Gcg- or Tac1-98 
expressing cells using cultures derived from GcgVenus and Tac1iresCre /Rosa26tdTomato mice11,16. 99 
Live-cell imaging of GcgVenus organoids demonstrated that BMP activation induced a decrease in 100 
Venus levels, suggesting downregulation of Gcg (Fig. S2e-f). We did not observe BMP-induced 101 
apoptosis of Venus+ or tdTomato+ cells (Fig. S2g).  102 
Changes in hormone expression in individual EECs might be caused by dynamics in 103 
transcriptional networks, and accompanied by production of other sensory receptors. To identify 104 
dynamics at a single cell level, we performed single cell RNA sequencing of traced Tac1-, Glp1- 105 
or Gip-expressing murine cells16. Gip+ K-cells exist both in crypts and villi and were isolated 106 
from organoids derived from a GipCre /Rosa26tdRFP mouse17. Guided by their regional in vivo 107 
abundance, we isolated organoids from the proximal SI of the Gip-, from the distal SI of Gcg- 108 
and from the whole SI of Tac1 reporter mice. Organoids were treated with a MEK inhibitor to 109 
limit new EEC generation and either exposed to Noggin (control) or BMP4 for 24 or 96 hours 110 
(Fig. 3a). Next, EECs derived from the reporters/treatments were sorted for the reporter 111 
fluorescence and single cell RNA sequencing was performed using SORTseq18, an automated 112 
version of CELseq2 (Fig. 3a, S3a)19. K-medoids clustering by RaceID2 algorithm20 showed that 113 
Tac1-, Gcg- and Gip-traced cells, classically defined as ECs, L- and K- cells respectively, 114 
clustered accordingly to their cell-type and mostly independently of the treatment in a t-SNE 115 
space (Fig. 3b-c). We identified Alpi+ enterocytes and Muc2+ Goblet cells derived from the 116 
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GcgVenus reporter that displayed the lowest Venus fluorescence intensity (Fig. S3b). We also 117 
detected  a cluster of unknown identity with expression of the vomeronasal receptor Vmn2r55, 118 
which was identified previously7. BMP-stimulated ECs displayed lower Sct expression 119 
compared to L- and K-cells (Fig. 3c-e). Within ECs, expression of Tph1 remained unchanged 120 
during BMP treatment, while Tac1 decreased (Fig. 3c-e). Cells clustering as classical L-cells 121 
dramatically reduced their Gcg (Glp1) expression, while activating Nts and Pyy transcription 122 
following BMP treatment (Fig. 3d and S3c). Some GcgVenus-sorted cells from ileal organoids 123 
expressed Gip, combined with low levels of Gcg (Fig. 3b-d). These cells clustered together with 124 
K-cells and could not be induced to express Nts, indicating that these cells represent K-cells and 125 
not L-cells. (Fig. 3d). L-cells and to a lesser extent K-cells express Cck independent of treatment 126 
(Fig. 3d). Within Gip-traced K-cells, we observed a separate population of Sst-producing cells. 127 
BMP activation had no effect on Sst expression and caused a mild reduction in Gip expression in 128 
these clusters, while activating Sct expression only in Gip+ but not in Sst+ cells (Fig. 3d-e, S3c). 129 
Pyy expression could be induced in both Gip+ and in Sst+ cells, but to a lesser extent than in L-130 
cells (Fig. S3c). We did observe low Cck, Gcg and no Nts expression in K-cells, indicating that 131 
these represent a separate lineage from ileal L-cells (Fig. 3d-e).  132 
 We identified uniquely expressed genes in the various clusters, that corresponded to 133 
known expression or function along the crypt-to-villus axis in vivo. The irritant receptor Trpa1 134 
(proposed to be involved in serotonin release) has been shown to be enriched in the crypt 15,21.  135 
Concordantly, it decreases during BMP treatment within ECs (Fig. 3d-e). We find the orphan 136 
receptor Asic5 to be expressed by Sst+ cells (Fig. S3d). This same population also expresses the 137 
islet amyloid polypeptide (Iapp) Amylin (Fig. S3d), a peptide previously found in pancreatic β-138 
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cells and known to have a wide range of metabolic effects22.  The LIM homeobox factor Lmx1a 139 
occurs in ECs, as suggested recently23. The homeobox protein Hhex -not previously observed in 140 
the gut- was expressed by Sst-producing cells (Fig. S3d). Interestingly, it has been described as 141 
an essential factor for Sst-producing δ cells in the pancreas24. The T-box transcription factor 142 
Tbx3 is produced in BMP-activated EECs (Fig. S3d), and is enriched in the villus25. Finally, we 143 
find specific activation of classical BMP target genes in BMP-treated cells, such as Id1, Id2 and 144 
Id3, confirming pathway activation (Fig. S3d)26.  145 
Transcript dynamics might not be fully predictive for changes at the peptide hormone 146 
level. Therefore, we repeated the same experimental strategy as for the single cell RNA 147 
sequencing and assessed co-expression of relevant peptide hormones in the Tac1iresCre 148 
/Rosa26tdTomato- and GcgVenus- reporter organoids. Over the course of 4 days, BMP-inhibited 149 
tdTomato+ cells remained immunoreactive for Tac1 and Serotonin, while only rarely expressing 150 
Sct (Fig S4a). Strikingly, BMP-activated tdTomato+ cells lost Tac1 immunoreactivity, 151 
maintained Serotonin and gained Sct positivity (Fig S4a). Glp1 positivity was strongly correlated 152 
with Venus expression in GcgVenus organoids in BMP-untreated conditions, while this correlation 153 
is lost in BMP-treated samples (Fig. S4a). Conversely, Venus positivity was increasingly 154 
predictive for Sct expression after BMP treatment (Fig. S4a). Pyy peptide positivity remained 155 
unchanged irrespective of BMP treatment (Fig S4a), in line with the constant peptide levels 156 
between crypt and villus in vivo10.  157 
We performed live cell imaging of the Tac1iresCre /Rosa26tdTomato- and GcgVenus- reporter 158 
organoids in BMP-untreated and -treated conditions. tdTomato+ cells that existed at the 159 
beginning of the BMP treatment continued to persist over the course of 60 hours, while losing 160 
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Tac1 and gaining Sct expression (Fig. S4b). Untreated cells retained Tac1 positivity (Fig. S4b). 161 
In GcgVenus- reporter organoids, we observed a similar increase in Sct peptides (Fig. S4b). 162 
Collectively, these data indicated that individual EECs can rewire their peptide hormone profile 163 
upon activation of BMP signaling. 164 
The number of tdTomato+ and Venus+ EECs increased significantly more over 4 days when BMP 165 
signaling is inhibited compared to when activated (Fig. S4a). We found that the first transcription 166 
factor expressed by and defining the EEC lineage, Neurogenin 327, is inhibited by BMP 167 
activation (Fig. S4c). To circumvent a bias that occurs at the bulk population level due to this 168 
inhibition of EEC specification, we first generated a large pool of ileal EECs using our 169 
differentiation protocol for 3 days. Next, we switched to BMP-high conditions for 24 hours (Fig. 170 
S4d). Increases in Sct, Pyy and Nts expression were more pronounced compared to a continuous 171 
BMP inhibition (Fig. 2 and Fig. S4c). These data imply that initial EEC specification requires 172 
BMP low conditions, such as exists at the bottom of the crypt.   173 
To investigate whether villus-produced BMP controls hormone expression in vivo, we 174 
analyzed intestines from mice that ectopically express BMP inhibitor Noggin in the intestinal 175 
epithelium (VillinNoggin)13. As expected, we observed an increased expression of Tac1 and Glp1 176 
in the villi of these mice, while Sct was reduced (Fig S5a-d). We next tested the feasibility of 177 
influencing hormone expression by targeting the BMP gradient with the BMPR1a inhibitor 178 
LDN19318928. An 80-hour oral treatment caused a reduction in Sct+ cell numbers. Overall 179 
histology of the intestine was unaffected, and the number of Chga+ EECs did not change 180 
significantly (Fig. 4a-b), consistent with a previous study showing no change in Chga after BMP 181 
inhibition29. We quantified the numbers of Tac1+ and Glp1+ along different segments of the 182 
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crypt-villus axis, assuming that BMP inhibition would not increase these in the BMP-low crypt. 183 
BMP inhibition did not cause significant changes in the lowest crypt-villus segment in the 184 
number of Tac1+ or Glp1+ EECs (Fig. 4a, 4c). However, the increase in cells immunoreactive for 185 
Tac1 or Glp1 was very pronounced higher up in the villus (Fig. 4a, 4c). 186 
 Finally, we pursued the establishment of a differentiation platform for induction of EECs 187 
in human intestinal organoids30. Best results were obtained with dual inhibition of Notch and 188 
MEK signaling (Fig. 5a-b). This allowed us to generate all subtypes of EECs in organoids either 189 
derived from human duodenal or ileal tissue. ENR differentiated organoids did not contain EECs 190 
but mostly enterocytes, as evidenced by their extensive brush border (Fig. 5a). In our EEC 191 
differentiation protocol, BMP activation induced similar trended alterations in EEC hormone 192 
repertoires as it did in murine organoids (Fig. 5c). NTS and SCT transcripts increased upon BMP 193 
stimulation, while we observed a dramatic reduction in GCG (Fig. 5c). BMP activation had a 194 
neutral effect on total CHGA expression, and in contrast to the mouse, PYY was not increased 195 
upon BMP stimulation (Fig. 5c). Although cells positive for both GLP1 and NTS peptides were 196 
observed in control conditions, we only observed NTS single positive cells in BMP-treated 197 
conditions (Fig. 5d). This implies that BMP-control of the expressed EEC hormone repertoire is 198 
a generalizable phenomenon. In line with our observations in the murine organoid system8, we 199 
find that human intestinal organoids maintain their regional identity in terms of representation of 200 
EEC subtypes. GCG, NTS and PYY were highly enriched in distal gut organoids, while CCK 201 
displays a much higher bias towards the duodenum (Fig. 5c). 202 
 Taken together, these data provide two main insights into EEC biology. First, the 203 
observations support that BMP controls hormone expression of EECs. EECs that are born in 204 
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crypts from Lgr5 stem cells encounter increasing levels of BMP signaling when migrating 205 
towards the villus tips31, and can change their hormone profile during this journey. Second, this 206 
insight in combination with the single cell sequencing data proposes a simplification of EEC 207 
taxonomy (Fig. 5e). Confusingly, previous high resolution imaging and single cell RNA 208 
sequencing has suggested that almost every combination of EEC hormones can occur in 209 
individual EECs32. Our current data indicate that there might be fewer unrelated differentiation 210 
pathways of EECs ('lineages') than previously anticipated and that some of the marker-hormones 211 
indeed are not hard-wired. Our data imply that there might exist no EECs uniquely dedicated to 212 
the production of Sct or Nts (the so called S- or N-cells) or Pyy, and that most EECs initiate 213 
expression of Sct when entering the BMP-high villus domain. Indeed, we observe that all BMP-214 
activated EECs except D-cells upregulate Sct to different degrees, while L-cells (but not Sst- or 215 
Serotonin-producing cells) increase Pyy and Nts. Gip-expressing cells can be induced to express 216 
lower levels of Pyy, but not Nts. Importantly, we find that Chga is a marker of Serotonin-positive 217 
cells but not of other EECs, and using it as a generic marker would not allow for identifying EEC 218 
regulators such as the BMP pathway. 219 
Pulse-chase labeling using BrdU has indicated that EECs do not necessarily follow the conveyor-220 
belt migration pattern in which cells follow a constant flow from the bottom of the crypt to the 221 
tip of the villus12,33. Recently it has been shown that EECs can physically interact with enteric 222 
neurons through synapses, which potentially could alter cellular migration 34,35. Subpopulations 223 
of EECs can be retained in the crypt for 2 weeks while maintaining expression of Tac1 or Glp1. 224 
Cells that migrate onto the villus are destined to lose Tac1 or Glp19,12,33. This ultimately suggests 225 
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that controlling EEC migration along the crypt-villus axis and the Wnt and BMP gradients would 226 
be a way to influence hormone expression patterns.  227 
  228 
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Figure legends 229 
Fig. 1 Enteroendocrine cells switch hormone expression while migrating from crypt to 230 
villus.  a and b, Immunohistochemical analysis reveals Glp1+ cells are enriched in the ileal crypt, 231 
where they co-express Pyy. Experiment in (a) was repeated two times independently with similar 232 
results. c, Quantification of b. The percentage of Pyy+ cells that co-express Glp1 are represented 233 
in the lower chart. d, ECs express Tac1 in the crypt and Sct in the villus, while Serotonin is 234 
produced in both locations. e, Quantification of d. The percentage of Serotonin+ cells that co-235 
express Tac1 or Sct are represented in the lower charts. f, Intestine of Tac1iresCre /RosaAi14 mice 236 
reveals that ECs lose Tac1 and gain Sct expression from crypt to villus. g, Quantification of (f) 237 
and Fig S1. The percentages of each hormone that is tdTomato+ (upper chart) and of tdTomato+ 238 
cells that are hormone positive (lower chart) are shown. The mean values are depicted in graphs 239 
c, e and g, and error bars present SD for n=4 mice for each experiment. Scale bar is 50 µm. 240 
Fig.2 Activation of BMP signaling induces Villus-like hormone signature in mouse EECs.      241 
a, Organoids are differentiated for 4 days to EECs in the absence (EEC BMPlow) or presence of 242 
BMP4 (EEC BMPhigh). ENR is used as a control. Activation of BMP signaling induces 243 
expression of Sct, while repressing Tac1 and Glp1. Images are presented as maximum 244 
projections. b, Quantification of a. The number of positive cells for each hormone were 245 
quantified and are displayed per mm of organoid epithelium. The percentage of Serotonin+ cells 246 
that co-express Tac1 are presented. Sample size represents n=2 biologically independent 247 
experiments, in which at least 3 organoids were quantified per replicate and staining. Statistics 248 
were derived comparing all organoids (n=12 for Sct, n=6 for other hormones) in BMP low and 249 
high conditions using a two-sided t-test. Mean values per treatment are shown, and error bars 250 
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present SD. c, Overlay of brightfield and Venus image of organoids derived from GcgVenus mice 251 
after a 4 day treatment with a BMPlow or BMPhigh EEC differentiation cocktail. BMP 252 
activation represses expression of Gcg, without inducing morphological alterations. Experiment 253 
was repeated independently 10 times. d, Volcano plots showing results from RNA sequencing of 254 
organoids stimulated for 4 days with BMP low or high EEC differentiation cocktails, from 255 
proximal (left) and distal (right) SI organoids. Gene expression fold change (log2) of BMPhigh 256 
versus BMPlow is shown on the x-axis and significance on the y-axis. Each grey dot represents a 257 
gene, and dots representing relevant genes are highlighted in different colors, according to their 258 
function. Sample size represents n=2 biologically independent experiments, and p-adjusted 259 
values were calculated with a Wald test using the DESeq2 package.    e, qPCR analysis of 260 
selected hormones from d. Expression levels are shown relative to control organoids in ENR 261 
medium. Experiment was performed in n=2 biologically independent experiments, and the mean 262 
expression is depicted. Scale bar is 50 µm. 263 
Fig.3 Single cell RNA sequencing reveals BMP regulated plasticity among different EEC 264 
subtypes. a, Experimental paradigm. Different EEC reporter organoids were treated with a MEK 265 
inhibitor, while receiving Noggin or BMP4. After 4 days, organoids were dissociated and traced 266 
EECs sorted and processed for single cell RNA sequencing. b and c, t-SNE map of single cell 267 
RNA sequenced EECs using the RaceID2 algorithm. Different colors, as indicated in the legend, 268 
highlight cells isolated from different reporter organoids (b) and treatments (c). d, Expression 269 
levels of selected hormones and receptors in the tSNE space of (b-c). e, Expression of individual 270 
hormones within different EEC reporter sorted cells are presented in violin plots, with different 271 
colors for the different treatments (as indicated in the legend). Violin plots depict median values 272 
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(white dot), 50% of the values (within thick black line) and 95% of the values (within thin black 273 
line). The number of cells per treatment and reporter is depicted. Different dynamics of hormone 274 
expression were observed over the course of BMP treatment in subtypes of EECs.  275 
Fig. 4 Manipulation of BMP gradient alters hormone expression in mice. a, Mice were 276 
treated for 80 hours with BMPr1a inhibitor LDN193819. Immunohistochemical analysis of the 277 
intestine shows a repression of Sct and induction of Glp1 and Tac1 expression upon BMP 278 
inhibition. Glp1+ and Tac1+ expressing cells are mostly restricted to the crypt in control mice, but 279 
expand into the upper villus region upon BMP inhibition. b, Quantification of a. Number of 280 
Chga+ and Sct+ positive cells per treatment. c, Quantification of a. Number of Tac1+ or Glp1+ 281 
cells are displayed for each segment of the crypt-villus axis in the different treatments. Cells 282 
positive for Tac1 and Glp1 increase in the higher villus segments upon LDN193189 treatment. 283 
Tac1+ cells are counted and displayed in 10mm of the proximal small intestine. Glp1+ cells are 284 
counted and displayed in 30mm of the distal small intestine. Results presented are derived from 285 
n=4 mice per treatment, and statistics were calculated using a two-sided t-test. Mean values per 286 
staining and treatment are shown, and error bars present SD. Scale bar is 50 µm.  287 
Fig. 5 New human EEC differentiation protocol implies conserved BMP-controlled 288 
hormone expression. a, Human small intestinal organoids were induced to  differentiate either 289 
for 5 days by withdrawing Wnt signals (ENR) or to EECs through additional MEK and Notch 290 
inhibition. Immunofluorescence indicates the presence of different subtypes of EECs in human 291 
organoids. White arrows indicate NTS+ cells, red arrows GLP1+ cells.  Experiment has been 292 
repeated four times independently with similar results. b, Brightfield images of human intestinal 293 
organoids in expansion medium or after a 5 day differentiation towards EECs. Experiment was 294 
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repeated independently four times. c, The 5-day differentiation protocol of EECs (‘humanEEC’) 295 
was performed in the presence and absence of BMP4. Expression levels of hormones were 296 
determined by qPCR and are shown relative to duodenal ENR control. Gcg expression is shown 297 
relative to ileal ENR control, as it was not detected in duodenal organoids. Sample size 298 
represents n=2 biologically independent experiments, and the mean expression values are shown. 299 
d, Human EECs were produced in the absence (BMPlow) or presence (BMPhigh) of BMP4. 300 
NTS overlaps with GLP1 in BMP low conditions, while only NTS single positive cells are 301 
observed in BMPhigh conditions. Experiment was repeated independently four times. Scale bar 302 
is 50 µm. e, Model of EEC differentiation. K-cells are enriched in the proximal and L-cells in the 303 
distal part of the SI respectively, whereas ECs and D-cells are uniformly distributed. A crypt-to-304 
villus BMP signaling gradient drives alterations in hormone repertoires in these EEC lineages. 305 
 306 
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 315 
 316 
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Methods 1 
Mouse strains and experiments 2 
Primary organoid cultures used in this culture were derived from GcgVenus , Tac1iresCre 3 
/Rosa26tdTomato and GipiresCre /Rosa26tdRfp mice11,16, and established as described before6. All mice 4 
were bred on a C57BL/6 background. All animal procedures and experiments were performed in 5 
accordance with national animal welfare laws under a project license obtained from the Dutch 6 
Government, and were reviewed by the Animal Ethics Committee of the Royal Netherlands 7 
Academy of Arts and Sciences (KNAW). All rodents are housed in a barrier facility in 8 
conventional cages and are changed without using a change stations. All personnel entering the 9 
barrier must wear protective clothing (including head caps, specials clogs). All animals are 10 
received directly from approved vendors (Charles River) or generated in house. Animals arriving 11 
from other sources must pass the GDL –quarantine for screening or by embryo-transfer. After 12 
screening these SPF mice are housed in micro isolator cages and are transferred to the Hubrecht 13 
laboratory. 14 
For the BMPR inhibition experiment, LDN193189 (Selleckchem) was dissolved in citric buffer 15 
(pH3-3.1) at 2mg ml-1. 12 week old mice (n=4) were given two oral doses of LDN193189 at 17.5 16 
mg per kg bodyweight per day. Citric buffer was given to control mice. The total treatment was 17 
maintained for 80 hours.   All mouse experiments were conducted under a project license granted 18 
by the Central Committee Animal Experimentation (CCD) of the Dutch government and 19 
approved by the Hubrecht Institute Animal Welfare Body (IvD), with project license number 20 
AVD8010020151. 21 
 22 
 23 
Murine and human intestinal organoid culture 24 
The basic culture medium (advanced Dulbecco’s modified Eagle’s medium/F12 supplemented 25 
with penicillin/streptomycin, 10 mM HEPES, Glutamax, B27 [Life Technologies, Carlsbad, CA] 26 
and 1 mM N-acetylcysteine [Sigma]) was supplemented with 50 ng/ml murine recombinant 27 
epidermal growth factor (EGF; Peprotech, Hamburg, Germany), R-spondin1 (conditioned 28 
medium, 5% final volume), and Noggin (conditioned medium, 5% final volume), called ‘’ENR’’ 29 
medium. Conditioned media were produced using HEK293T cells stably transfected with HA-30 
mouse Rspo1-Fc (gift from Calvin Kuo, Stanford University) or after transient transfection with 31 
mouse Noggin-Fc expression vector. Advanced Dulbecco’s modified Eagle’s medium/F12 32 
supplemented with penicillin/streptomycin, and Glutamax was conditioned for 1 week. 33 
Human duodenal and ileal tissues were obtained from the UMC Utrecht with informed consent 34 
of each patient. The study was approved by the UMC Utrecht (Utrecht, The Netherlands) ethical 35 
committee and was in accordance with the Declaration of Helsinki and according to Dutch law. 36 
Patients were diagnosed with a small or large intestinal cancer and from the resected intestinal 37 
segments, a sample was taken from normal mucosa for this study. Human small intestinal cells 38 
were isolated, processed and cultured as described previously30. 39 
Organoids were plated in BME (Trevigen). MEK signaling was inhibited using PD0325901 40 
(1 μM for murine, 100nM for human organoids; Sigma Aldrich). Wnt secretion was inhibited 41 
with IWP-2 (5 μM; Stemgent) and Notch with DAPT (10uM, Sigma Aldrich). BMP signaling 42 
was activated by treating with human recombinant BMP4 (20ng/ml, Peprotech) and withdrawal 43 
of Noggin from the culture medium. Hedgehog signaling was inhibited with Vismodegib (10uM, 44 
Selleckchem). TGF beta signaling was activated using recombinant mouse TGF beta-1 (3ng ml-1, 45 
R&DSystems, MAB7666TGF beta-1. TGF beta type1 receptor signaling was inhibited using 46 
A83 (500nM, Tocris). All control organoids were treated with similar concentrations of the 47 
compound dissolvent, dimethyl sulfoxide (DMSO) or 0.1%BSA in PBS0. During treatments, 48 
cells were imaged using an EVOS microscope (Electron Microscopy Sciences). 49 
For the induction of enteroendocrine differentiation in murine organoids, cells were cultured in 50 
standard culture conditions (ENR). 4-7 days after plating in BME, medium was removed and 51 
organoids were treated with different regimes. The cocktail for mouse EEC differentiation 52 
included: IWP2 (5 μM; Stemgent), DAPT (10 μM, Sigma Aldrich) and MEK inhibitor 53 
PD0325901 (1 μM; Sigma Aldrich), while BMP4 (20ng/ml, Peprotech) was added for activation 54 
of BMP signaling. In human organoids, differentiation was achieved by withdrawing p38 MAPK 55 
inhibitor SB202190, TGFbeta inhibitor A83, Nicotinamide and Wnt conditioned medium from 56 
the culture medium as described previously30. Differentiation into EECs was performed by on 57 
top treating with DAPT (10 μM, Sigma Aldrich) and MEK inhibitor PD0325901 (500nM; Sigma 58 
Aldrich), BMP4 (20ng/ml, Peprotech) was added for activation of BMP signaling. 59 
Immunostainings  60 
Whole organoids were collected by gently dissolving the BME in ice-cold medium, and 61 
subsequently fixed at RT in 4% formalin (Sigma) for at least 6 hours. Next, organoids were 62 
permeabilized and blocked in PBS containing 0,5% Triton X-100 (Sigma) and 2% normal 63 
donkey serum (Jackson ImunoResearch) for 30 min at room temperature. Organoids were 64 
incubated for 2 hr at room temperature in blocking buffer containing primary antibodies. Primary 65 
antibodies used were goat anti-Chromogranin A (1:500; Santa Cruz), goat anti-Cholestocystokin 66 
(sc-21617,1:100; Santa Cruz), rabbit anti-Neurotensin (sc-20806,1:100; Santa Cruz), goat anti-67 
Secretin (sc-26630,1:100; Santa Cruz), goat anti-Somatostatin (sc-7819, 1:100; Santa Cruz), goat 68 
anti-Serotonin (ab66047, 1:1000, Abcam), rabbit anti-Gastric inhibitory polypeptide (ab22624-69 
50, 1:500;Abcam), goat anti-GLP1 (sc-7782, 1:100; Santa Cruz), rabbit anti-GLP1 (ab22625, 70 
1:200; Abcam), rabbit anti-Peptide YY (ab22663, 1:500; Abcam) and guinea pig anti-Substance 71 
P (1:200, ab10353; Abcam). Organoids were incubated with the corresponding secondary 72 
antibodies Alexa488, 568 and 647 conjugated anti-rabbit and anti-goat (1:1000; Molecular 73 
Probes) in blocking buffer containing DAPI (1;1000, Invitrogen). Sections were embedded in 74 
Vectashield (Vector Labs) and imaged using a Sp8 confocal microscope (Leica). Image analysis 75 
was performed using ImageJ software. 76 
For immunohistochemistry of organoids within the BME (Figure S4), medium was removed 77 
from the wells and replaced with 4% formalin for 1 hour. Next, organoids were washed with 78 
PBS, permeabilized and blocked in PBS containing 0,5% Triton X-100 (Sigma) and 2% normal 79 
donkey serum (Jackson ImunoResearch) for 30 min at room temperature. The wells were 80 
incubated for 2 hr at room temperature in blocking buffer containing primary antibodies. After 81 
washing, secondary antibodies were added for 1 hr at room temperature in blocking buffer. 82 
Organoids were subsequently imaged within the plate using a Sp8 confocal microscope (Leica). 83 
For immunohistochemistry of mouse intestinal tissue, intestines were first flushed with 4% 84 
formaldehyde. Next, intestines were fixed for 6 hours at RT in 4% formalin. The tissue was 85 
either embedded in paraffin or Tissue-Tek O.C.T. for cryosectioning, and stained as described 86 
previously6,36.  87 
Quantification of number/location of EECs on intestinal section images were performed in 88 
ImageJ software, as well as the intensity of Venus levels in the live cell imaging experiment in 89 
Figure S2e-f. Analysis of Glp1+   cell numbers and/or position in Figure 1a-c, Figure 4a-c and 90 
Figure S5 were performed in the ileum, and all other hormones were counted along the whole SI 91 
tract.   92 
All quantifications were performed on the raw, unprocessed images.  93 
RNA isolation and quantitative PCR 94 
For qPCR analysis and bulk RNA sequencing, RNA was isolated from organoids using the 95 
RNAeasy kit (QIAGEN) as instructed in the manufacturer’s protocol. PCR analysis was 96 
performed using the SYBR-Green and Bio-Rad systems as described37. PCR reactions were 97 
performed in duplicate with a standard curve for every primer. Changes in expression were 98 
calculated using CFX manager software (Bio-Rad). Primers were designed using the NCBI 99 
primer design tool. Primers used in this study are presented in Supplementary Table 1. 100 
 101 
Glp1 and Secretin secreted peptide 102 
The supernatant from organoids was collected after 2-hour stimulation with Forskolin. GLP-1 103 
concentration in the supernatant was measured with a GLP-1 EIA Kit (Rab0201, Sigma, detects 104 
both full length and N-terminal cleaved GLP-1) using the manufacturer’s protocol. Secretin 105 
concentration was measured with a Secretin EIA kit (EK-067-04, Phoenix Pharmaceuticals) 106 
using the manufacturer’s protocol.   107 
 108 
Statistical analysis 109 
Two sided t-tests were performed for all statistical analyses. Precise p-values are mentioned in 110 
the corresponding figures, and significance level was set at p < 0.05. In each figure legend, the 111 
number of biology replicates is mentioned for the corresponding experiment (n=x). For figures 112 
where representative images are shown, the number the experiment has been repeated is 113 
mentioned in the legend. 114 
For immunohistochemistry, we counted the following number of cells, of organoids or length of 115 
intestine; at least 50 cells per hormone and replicate intestine (Fig. 1b-e, n=4 mice), at least 150 116 
tdTomato+ cells per co-staining and replicate intestine (Fig. 1f-g, n=4 mice), at least 3 organoids 117 
per hormone and replicate (Fig. 2a-b, n=2 biologically independent experiments), 10 organoids 118 
per hormone and replicate (Fig. S4a, n=2 biologically independent experiments), 10mm of the 119 
proximal small intestine for Tac1 (Fig. 4b-c, n=4 mice per treatment), 30mm of the distal small 120 
intestine for Glp1 (Fig. 4b-c, n=4 mice per treatment). mice per genotype) and at least 50 cells 121 
per hormone and replicate intestine (Fig. S5b, n=2 mice per genotype),  122 
 123 
Bulk and single cell RNA sequencing 124 
For bulk RNA sequencing analysis, organoids stimulated with EEC BMPhigh or EEC BMPlow 125 
media for 4 days were collected and dissociated in RTL buffer (RNeasy Mini kit, Quiagen). 126 
Total RNA was isolated accordingly to manufacturer’s instruction (RNeasy Mini kit, Quiagen). 127 
Sequencing libraries were prepared based on a modified CELseq2 method19. Briefly, 1 ng of 128 
RNA was reverse transcribed using the Ambion kit and in vitro transcription was performed 129 
using 1 ng of cDNA as template. The aRNA was then used to prepare sequencing libraries. 130 
Samples were sequenced with sequenced paired-end at 75 bp read-length the on Illumina 131 
NextSeq.  132 
For single cell RNA sequencing, organoids were first dissociated into single cells through 133 
mechanical disruption, after 15 min of Trypsin treatment at 37°C (TrypLE Express; Life 134 
Technologies). Next, cells were immediately sorted using a BD FACS Aria (BD Biosciences). 135 
For single cell sequencing experiment, cells were sorted as single cells into 384-well plates 136 
containing ERCC spike-ins (Agilent), RT primers and dNTP (Promega) as described before. 137 
Plates were prepared using Mosquito® HTS (TTPlabtech). Single cell RNA-sequencing libraries 138 
were prepared following the SORT-seq protocol 18, which is based on CEL-seq2 method19. 139 
Briefly, cells were first lysed 5 min at 65°C, and RT and second strand mixes were dispensed by 140 
the Nanodrop II liquid handling platform (GC biotech). Single cell double stranded cDNAs were 141 
pooled together and in vitro transcribed for linear amplification. Illumina sequencing libraries 142 
were prepared using the TruSeq small RNA primers (Illumina) and sequenced paired-end at 143 
75 bp read length the Illumina NextSeq. 144 
RNA-sequencing data analysis 145 
Paired-end reads from Illumina sequencing were aligned to the mouse transcriptome genome by 146 
BWA38. For RNA-seq bulk data, normalization and differential gene expression analyses were 147 
performed using the DESeq2 package39 and visualized as volcano plots. For single cell RNA-seq 148 
data, read counts were first corrected for UMI barcode by removing duplicate reads that had 149 
identical combinations of library, cell-specific, and molecular barcodes and were mapped to the 150 
same gene. For each cell barcode the number of UMIs for every transcript was counted, and 151 
transcript counts were then adjusted to the expected number of molecules based on counts, 256 152 
possible UMI’s and poissonian counting statistics40. Samples were then normalized by 153 
downsampling to a minimum number of 3000 transcripts/cell. Cells with fewer transcripts were 154 
excluded from the analyses. RaceID2 was used to cluster cells based on k-medoid method 20. All 155 
data analyses, quantification and data visualization were run on Rstudio.  In total, we sequenced 156 
2880 cells and, after applying a filtering criteria of 3000 expressed transcripts/cell, 820 cells 157 
were retained for further analysis. 158 
 159 
 160 
Data availability 161 
Bulk and single-cell RNA–seq data that support the findings of this study have been deposited in 162 
the Gene Expression Omnibus (GEO) under accession code GSE114988.  163 
 164 
Source data for Fig. 1c, 1e, 1g, 2b, 2e, 4a, 5b, 5c, 6b and Supplementary Fig. 1a, 2a, 2b, 2d, 3b, 165 
4b, 4c, 5a, 5b and 6 have been provided as Supplementary Table 2. All other data supporting the 166 
findings of this study are available from the corresponding author on reasonable request. 167 
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